Rise in codeine abuse in South Africa prompts new regulatory measures

Rise in codeine abuse in South Africa prompts new regulatory measures

Copelyn also highlights a worrying trend among people who were initially prescribed codeine-based painkillers and who gradually developed addiction.

In response, the South African Health Products Regulatory Authority (SAHPRA) has issued a draft directive to monitor suspicious sales of codeine.

Under the new draft guidelines, SAHPRA can request sales data and other relevant information from manufacturers, suppliers and distributors of scheduled medicines.

This measure aims to track the flow of codeine from its production to its final distribution, thus improving the monitoring and control of its distribution.